Clinical Trial

A Study of Firsekibart Versus Anakinra in Adult-Onset Still's Disease

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to compare the efficacy and safety of firsekibart versus anakinra in patients with AOSD.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-17.
Status change: Not Yet Recruiting → Recruiting 2026-04-09
Trial Details
NCT Number NCT07191444
Lead Sponsor Ruijin Hospital
Conditions Still's Disease, Adult-Onset
Enrollment 20 participants
Start Date 2025-09-24
Primary Completion 2026-12-01 (estimated)
Study Completion 2027-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-13